Oryzon GenomicsMEX:ORYN 31 OCF Yield % is -0.97 as of Jun. 25, 2026. GuruFocus rates MEX:ORYN with a GF Score™ of 31/100. Among 1,419 Biotechnology companies, Oryzon Genomics ranks better than 74.63% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Oryzon Genomics OCF Yield % Related Terms
Oryzon Genomics OCF Yield % Historical Data
* Premium members only.
The historical data trend for Oryzon Genomics's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:ORYN vs VRTX, REGN, ALNY: OCF Yield % Comparison
For the Biotechnology subindustry, Oryzon Genomics's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oryzon Genomics OCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Oryzon Genomics's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Oryzon Genomics's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oryzon Genomics (MEX:ORYN) has a OCF Yield % of -0.97 as of Jun. 25, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Oryzon Genomics and its competitors. According to the industry distribution chart, Oryzon Genomics ranks #360 out of 1419 companies in the Biotechnology industry, placing it in the top 25.4%.
Is Oryzon Genomics' OCF Yield % too high?
Oryzon Genomics' current OCF Yield % is -0.97. Based on the distribution chart, Oryzon Genomics ranks #360 out of 1419 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Oryzon Genomics has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Oryzon Genomics' OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Oryzon Genomics ranks #360 out of 1419 companies for OCF Yield %. This puts Oryzon Genomics in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Oryzon Genomics and its competitors. Oryzon Genomics's current OCF Yield % is -0.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oryzon Genomics stock overvalued right now?
Oryzon Genomics (MEX:ORYN) has a current OCF Yield % of -0.97. The current OCF Yield % is -0.97. Oryzon Genomics' overall GF Score™ is 31/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Oryzon Genomics (MEX:ORYN), the current OCF Yield % is -0.97 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.
31GF Score
Get the complete analysis for MEX:ORYN
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ORYN has been successfully added to your 
